跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VINORELBINE EBEWE 50 mg/5 mL (as tartrate) injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
VINORELBINE EBEWE 50 mg/5 mL (as tartrate) injection vial
Approved
STANDARD
VINORELBINE EBEWE 50 mg/5 mL (as tartrate) injection vial
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d3e1e30f9ccd5bcb
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
d3e1e30f9ccd5bcb
Product Name
VINORELBINE EBEWE 50 mg/5 mL (as tartrate) injection vial
Artg Id
99724
Artg Name
VINORELBINE EBEWE 50mg/5mL (as tartrate) injection vial
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2006-04-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/497a7215b051f64f6feb1e14360aa43f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/fce6fb99a778efc64fbb6ddf077ba8f7.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d3e1e30f9ccd5bcb
Type
Standard
Back to TGA Approvals